Form 8-K VERTEX PHARMACEUTICALS For: Jul 29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mail
http://archive.fast-edgar.com/20140729/A3K2S222Z229Q272222W22Z2MSTJYZ22A262
Filed on: July 29, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vortex Energy Receives Government Approval for Ground Gravity Survey at Robinsons River Salt Project
- Chronic Spontaneous Urticaria Clinical Trials Update 2026: Phase-Wise Pipeline Status, Drug Profiles, and Key Developers | Allakos, AstraZeneca, Biosana, Celldex Therapeutics, Celltrion, Eli Lilly
- Vertex Appoints Daniel Brennan to its Board of Directors
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
